After 20 years of clinical research in immune tolerance therapies researchers are getting closer to finding ways to delay or prevent type 1 diabetes. If you are related to someone with T1D, you are in a unique position to help.
A promising immune therapy may stop or slow down the autoimmune reaction that causes type 1 diabetes (T1D). Anti-CD3 may change the course of the disease in those with the highest risk of developing T1D.
What are people saying about anti-CD3 immune therapy? Is the medical scientific community behind anti-CD3 for type 1 diabetes? Find links to press and journal articles that tell the story of anti-CD3.